Advisory Committees

April 17, 2013 Cellular, Tissue and Gene Therapies Advisory Committee Meeting Agenda

Food and Drug Administration
Cellular, Tissue and Gene Therapies Advisory Committee
Meeting #58
April 17, 2013
Rockwall II Building, 5515 Security Lane, Rockville, MD
Conference Room 1033


 Open Session
1:30 p.m. (EST)Welcome and Administrative Remarks
Evan Snyder, M.D., Ph.D., Chair
Roll Call/Introduction of Members

Conflict of Interest Statement
Gail Dapolito, Designated Federal Officer
Center for Drug Evaluation and Research (CDER)
1:40Overview Research Programs
Office of Biotechnology Products (OBP), CDER
Steven Kozlowski, M.D., Director, OBP
Edward Max, M.D., Ph.D., Associate Director for Research, OBP
2:00Division of Therapeutic Proteins (DTP)
Amy Rosenberg, M.D., Director, DTP
2:15Research Program Summaries
Laboratory of Chemistry (LC)
Serge Beaucage, Ph.D., Chief (Acting), LC
2:45Gibbes Johnson, Ph.D., Deputy Director (Acting), DTP
3:15Open Public Hearing
4:15Closed Session
5:00 p.m.Adjourn

Page Last Updated: 08/14/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English